Single Bolus Recombinant Nonimmunogenic Staphylokinase (Fortelyzin) and Bolus Infusion Alteplase in Patients With AIS
Clinical trial NCT03151993 · COMPLETED
Trial details
- NCT number
- NCT03151993
- Sponsor
- Supergene, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-18
- Primary completion
- 2019-03-23
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.